Christopher Unsworth, Ph.D., is an Associate Director of Business Development at OCR.  His primary focus is the development of translational collaborations in the area of drug discovery and development, an example of which is the partnership between Yale and Evotec. Other responsibilities include the licensing and partnering of technologies in the Pharmaceutical, Diagnostic, Medical Imaging and Medical Device space.

Prior to his work at OCR, Chris was a senior scientist at Wellcome Research Labs, a research fellow at Massachusetts General Hospital, a research fellow at the University of Pennsylvania, and a senior research scientist and research licensing officer for Bayer.

Chris holds a B.Sc. in Biochemistry and Physiology from the University of Leeds, and a Ph.D. in Biochemical Pharmacology from Imperial College, University of London.